Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 6 7 8 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Acousia Therapeutics–Boehringer: investment, 201805 financing round Series B totalling €10m incl existing + co-investor BIVF 2018-05-14
Acousia Therapeutics–Bregua Corp: investment, 201805 financing round Series B totalling €10m incl new + co-investor Bregua Corp 2018-05-14
Acousia Therapeutics–Creathor Venture: investment, 201805 financing round Series B totalling €10m incl new + co-investor Creathor Venture 2018-05-14
Acousia Therapeutics–Germany (govt): investment, 201805 financing round Series B totalling €10m incl existing + co-investor KfW 2018-05-14
Acousia Therapeutics–Instinctif Partners: public relations, 201805 service existent by Instinctif 2018-05-14
Acousia Therapeutics–LBBW: investment, 201805 financing round Series B totalling €10m incl lead + new investor LBBW Venture Capital 2018-05-14
Acousia Therapeutics–SEVERAL: investment, 201805 financing round Series B €10m led by new investor LBBW Venture Capital 2018-05-14
Bluebird Bio–Medigene: TCR technology, 201805– collab strategic alliance expansion incl $8m one-time payment 2018-05-14
Polyneuron–SEVERAL: investment, 201805 seed financing round CHF3.1m led by EVA Basel + incl Zürcher Kantonalbank + private investors 2018-05-14
Valerius Biopharma–Catalent: contract manufacturing, 201805– collab cell line developm + manufacturing of speciality biosimilars using GPEx technology 2018-05-14
Armo BioSciences–Lilly: investment, 201805– acquisition $1.6b cash tender offer at $50/share by Eli Lilly 2018-05-10
Memo Therapeutics–Redalpine: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor Redalpine Venture Partners 2018-05-09
Memo Therapeutics–Schroders: investment, 201805 financing round Series A2 totalling CHF5m incl new investor Schroder Adveq 2018-05-09
Memo Therapeutics–SEVERAL: investment, 201805 financing round Series A2 CHF5m incl Schroder Adveq + investiere.ch + Redalpine Ventures et al. 2018-05-09
Memo Therapeutics–Verve Capital Partners: investment, 201805 financing round Series A2 totalling CHF5m incl new investor investiere.ch 2018-05-09
Memo Therapeutics–Zürcher Kantonalbank: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor ZKB 2018-05-09
PHAST–Eurofins: investment, 201805 acquisition of PHAST GmbH by Eurofins Scientific 2018-05-09
Bruker Corp–CMS: legal services, 201805 service legal advice by CMS on acquisition of Sierra Sensors GmbH by Bruker 2018-05-06
Bruker Corp–CMS: legal services, 201808 service legal advice by CMS on majority acquisition of Hain Lifescience by Bruker 2018-05-06
InflaRx–LifeSci: public relations, 201805 service existent IR by LifeSci Advisors + Media US by LifeSci Public Relations 2018-05-03
SmartDyeLivery–SEVERAL: investment, 201805 financing round from new investor STIFT + existing investors bm|t + Sparkasse Jena-Saale-Holzland 2018-05-03
Unisensor (BE)–Scienion: print/spotting technology, 201805 collab use of sciFlexarrayer techn for Extenso milk analysis platform 2018-05-03
Evotec–ERS Genomics: CRISPR technology, 201804– license €na to expand Evotec’s CRISPR-based service offering from ERS Genomics Ltd 2018-05-02
Genohm–Agilent: investment, 201805 acquisition €na of Genohm by Agilent 2018-05-02
InflaRx–SEVERAL: investment, 201805 primary public offering $51m+$7.65m w 1.5m+225k common shares at $34/share 2018-05-02
AdvanceCor–SEVERAL: investment, 201805 financing round €6m led by MIG AG + incl Occident Group + Bayern Kapital + HTGF + KfW Bank + founders 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
NovellusDx–SEVERAL: investment, 201804 financing round $6m incl investors Helsinn + BCIF + Windham Venture Partners 2018-04-30
Roche–4D Molecular Therapeutics: gene delivery technology, 201804– collab expansion to develop + commercialise ophthalmic gene therapy products 2018-04-30
Roivant–SEVERAL: investment, 201804 financing round $40.5m of Datavant led by Roivant Sciences + Travis May 2018-04-30
Universal Patient Key–Roivant: investment, 201804 acquisition of UPK by Datavant 2018-04-30
Curetis–Global Corporate Finance: investment, 201804–202103 equity facility $10m solely at Curetis request up to 36 months at pre-agreed floor pricing 2018-04-27
Curetis–SEVERAL: investment, 201804 capital increase €4.1m offering of 854k new ordinary shares at €4.8/share to qualified EU + US investors 2018-04-27
Polyphor–Consilium: public relations, 201804 service existent international media relations by CSC 2018-04-27
Boehringer–Topas Therapeutics: immuno modulatory compounds, 201804– collab €na multi-y research + option agreem 2018-04-24
Bosch–Randox: point-of-care diagnostics, –201804 collab developm test panels for Vivalytic POC analyser 2018-04-21
Merck (DE)–P&G: investment, 201804 acquisition €3.4b in cash of Merck’s consumer healthcare by P&G 2018-04-19
AiCuris–Max Planck: anti-infectives, 2018004– collab discovery of antibiotics + virostatic compounds extending existent collab with MPI-MP 2018-04-18
InterAx Biotech–LeadXPro: cancer immunotherapy, 201804– collab €na drug discovery + optimisation of lead molecules targeting GPCRs 2018-04-18
Novartis–Pear Therapeutics: digital health, 201804– collab developm + commercialisation of prescripition digital therapeutics for drug abuse Sandoz 2018-04-18
Tizona Therapeutics–Minapharm: biopharma production, 201804– supply service cell line + process developm + production of therap antibody by ProBioGen 2018-04-18
Anasys Instruments–Bruker Corp: investment, 201804 acquisition of Anasys by Bruker 2018-04-17
DiaMan–GlucoMe: digital health, 201804– collab product integration of GlucoMe + DiaMan products + marketing in Central America by DiaMan 2018-04-17
DKSH–Bruker Corp: analytical instruments, 201804– distribution multi-product line of Bruker AXS in KR + AU + NZ + SG + ID by DKSH Technology 2018-04-17
Biovertis–Deinove: investment, 201804–201805 acquisition of Biovertis/Morphochem for €900k in 500k new shares + 8m warrants 2018-04-13
Enterprise Therapeutics–Novartis: investment, 201804 financing round Series B totalling £29m ($41m) incl co-lead investor Novartis Venture Fund 2018-04-12
Enterprise Therapeutics–SEVERAL: investment, 201804 financing round Series B £29m ($41m) co-led by Versant Ventures + NVF 2018-04-12
Knauer–Microsaic: mass spectrometry, 201804– collab integration of Microsaic’s compact MS techn in Knauer’s LC platform 2018-04-12
Petra Pharma–Evotec: drug development services, 201804– supply service €na support developm of Petra-01 through to IND 2018-04-11
Roivant–Arbutus Biopharma: RNA drugs, 201804– collab founding of jv Genevant Sciences to develop RNA drugs using LNP technology 2018-04-11
Baliopharm–Promethera: investment, 201804 acquisition €na of Baliopharm AG by Promethera Biosciences SA 2018-04-10
Boehringer–Biomax: bioinformatics, 201804– license multi-year for BioXM s/w + license extension for BioRS s/w 2018-04-10
Promethera–MacDougall Biomedical Communications: public relations, 201804 service existent by MacDougall 2018-04-10
AveXis–Novartis: investment, 201804–201805 acquisition $8.7b in cash of AveXis Inc by Novartis for $128/share 2018-04-09
Grünenthal–Univ Leuven: pain drugs, 201804– collab r+d non-opioid pain drugs with CD3 + LICR 2018-04-09
Polyphor–SEVERAL: investment, 201804–201805 IPO CHF155m (€130m) at SIX Swiss Exchange at CHF38/share 2018-04-09
Boehringer–OSE Immunotherapeutics: antibody cancer drug, 201804– collab + license ww OSE-172 €30m upfront+short-term + €1.1b milestones + royalties 2018-04-04
Bravos Biosciences–Arsanis: therapeutic antibody, 201804– license pre-clin develop ww excl to ASN200 program + option further developm to BB100 LLC 2018-04-04
LCF Rothschild–Andera Partners: investment, 201804 management buy-out of EdRIP by employees + renaming to Andera Partners 2018-04-04
Brainomix–Boehringer: investment, 201804 financing round totalling £7m incl new + co-investor BIVF 2018-04-03
Brainomix–SEVERAL: investment, 201804 financing round £7m led by Parkwalk Advisors + incl BIVF + Chimera Partners + Oxford Univ 2018-04-03
Macrolide–Advent Venture Partners: investment, 201804 financing round totalling $20m incl existing investor Advent Life Sciences 2018-04-01
Macrolide–Bertarelli Group: investment, 201804 financing round totalling $20m incl existing investor Gurnet Point Capital 2018-04-01
Macrolide–GSK: investment, 201804 financing round totalling $20m incl existing investor SR One 2018-04-01
Macrolide–Novartis: investment, 201804 financing round totalling $20m incl existing investor Novartis Venture Fund 2018-04-01
Macrolide–Roche: investment, 201804 financing round totalling $20m incl existing investor Roche Ventures 2018-04-01
Macrolide–SEVERAL: investment, 201804 financing round $20m led by existing investors Advent LS + Gurnet Point + Novartis + Roche + SR One 2018-04-01
Novartis–GSK: investment, 201803– acquisition $13b of 36.5% stake of Novartis in OTC joint venture giving GSK 100% ownership 2018-03-27
PITBUL project–EU (govt): grant, 201803–2020 Horizon 2020 grant €3.8m to develop ultrafast PoC tuberculosis diagnostic platform 2018-03-24
NMD Pharma–ABP (NL): investment, 201803 financing round Series A totalling €38m incl new + lead investor Inkef Capital 2018-03-23
NMD Pharma–Lundbeck: investment, 201803 financing round Series A totalling €38m incl existing + co-investor Lundbeckfonden Emerge 2018-03-23
NMD Pharma–Novo Group: investment, 201803 financing round Series A totalling €38m incl existing + co-investor Novo Seeds 2018-03-23
NMD Pharma–Roche: investment, 201803 financing round Series A totalling €38m incl new + co-investor Roche Venture Fund 2018-03-23
NMD Pharma–SEVERAL: investment, 201803 financing round Series A €38m led by new investor Inkef Capital + incl RVF + Novo Seeds + Lundbeckfonden 2018-03-23
MorphoSys–SEVERAL: investment, 201803–201804 US IPO $208m+$31m with 8.3m+1.245m ADSs at $25.04/ADS + listing at Nasdaq Global Market 2018-03-22
Aton–Grifols: investment, 201803– acquisition 100% of Haema for €220 on a debt free basis by Grifols from Aton GmbH 2018-03-20
Novartis–Harvard Univ: drug delivery technology, 201803– collab develop biomaterial systems for delivery of cancer immuntherapies NIBR + Wyss + Dana 2018-03-20
Robert Bosch Hospital–bio.logis: genetic software, 201803– supply implementation of bio.logis GIMS IT platform at RBK 2018-03-20
Bruker Corp–KAUST: magnet resonance technology, 201803– collab establ KAUST-Bruker Center of Excellence in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 500 MHz super wide-bore MRI spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 900 MHz wide-bore NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 950 MHz NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply DNP NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
Biocatalysts Ltd–BRAIN: investment, 201803 acquisition of majority stake in Biocatalysts Ltd by BRAIN AG 2018-03-17
Mérieux–Sartorius: bioreactors, 201803 supply of single-use viral vector manufacturing package to ABL Europe in Strasboug by SSB 2018-03-16
Prexton Therapeutics–Lundbeck: investment, 201803– acquisition €100m upfront + €805m developm + sales milestones ANNOUNCED 2018-03-16
Siemens–SEVERAL: investment, 201803 IPO €4.2b of Siemens Healthineers AG at FSE floating 150m (15% of) shares at €28/share 2018-03-16
Boehringer–Vanderbilt Univ: MCL1 inhibitors, 201803– collab expansion r+d of MCL1 inhibitors for cancer 2018-03-13
Danaher–KAUST: microscopy, 201803– collab establ KAUST-Leica Center of Excellence in Optical Microscopy 2018-03-12
ImmBioMed–Sekisui: coagulation tests, 201803 acquisiton of specialty coagulation assets of Sekisui Diagnostics GmbH by ImmBioMed 2018-03-12
KAUST–Danaher: microscopy, 201803 supply SP8 confocal platform to new KAUST-Leica Center of Excellence in Optical Microscopy 2018-03-12
Medical Univ Vienna–bio.logis: genetic software, 201803 collab use of bio.logis GIMS.DRM with safety code card at MUW 2018-03-12
Atomwise–SEVERAL: investment, 201803 financing round Series A $45m co-led by Monsanto GV + DCVC (Data Collective) + B Capital Group 2018-03-07
Compugen–JSR Corp: cell line development, 201803– license to use Selexis’ SUREtechnology for developm of cancer antibody drugs incl COM701 2018-03-07
Novartis–Science 37: clinical research, 201803– collab 3y expansion up to 10 decentralised clinical trials 2018-03-07
Ventech–SEVERAL: investment, 201803 first closing €140m of Ventech Capital V fund with €200m target size 2018-03-07
Magenta Therapeutics–Heidelberg Pharma: antibody-drug conjugates, 201803– collab developm of ADCs for bone marrow transplant using ATAC platform 2018-03-05
abcr GmbH–Enzymicals: enzymes, 201803– collab distribution expansion ww catalogue sale of selected enzymes + enzyme-produced chemicals 2018-03-01
Affiris–PR&D: public relations, 201803 service existent by PR&D – Public Relations for Research & Education 2018-03-01
Heidelberg Pharma–MC Services: public relations, 201803 service existent by MC Services 2018-03-01
next pagenext page 1 2 3 ... 6 7 8 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

» top